EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Intranasal Nanotransferosomal Gel for Quercetin Brain Targeting: I. Optimization, Characterization, Brain Localization, and Cytotoxic Studies

Mohammed H Elkomy iD, Randa Mohammed Zaki, Omar A Alsaidan iD, Mohammed Elmowafy iD, Ameeduzzafar Zafar iD, Khaled Shalaby, Mohamed A Abdelgawad iD, Fatma I Abo El-Ela iD, Mostafa E Rateb iD, Ibrahim A Naguib iD, Hussein M Eid iD

Pharmaceutics · 23.06.2023 · 15 (7) · 1805

DOI: 10.3390/pharmaceutics15071805 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 23.06.2023. Verfasst von Mohammed H Elkomy und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, College of Pharmacy, Jouf University, Sakaka 72341, Saudi Arabia. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CSR NIH HHS, Deanship of Scientific Research at Jouf University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Numerous neurological disorders have a pathophysiology that involves an increase in free radical production in the brain. Quercetin (QER) is a nutraceutical compound that shields the brain against oxidative stress-induced neurodegeneration. Nonetheless, its low oral bioavailability diminishes brain delivery. Therefore, the current study aimed to formulate QER-loaded transferosomal nanovesicles (QER-TFS) in situ gel for QER brain delivery via the intranasal route. This study explored the impacts of lipid amount, edge activator (EA) amount, and EA type on vesicle diameter, entrapment, and cumulative amount permeated through nasal mucosa (24 h). The optimum formulation was then integrated into a thermosensitive gel after its physical and morphological characteristics were assessed. Assessments of the optimized QER-TFS showed nanometric vesicles (171.4 ± 3.4 nm) with spherical shapes and adequate entrapment efficiency (78.2 ± 2.8%). The results of short-term stability and high zeta potential value (−32.6 ± 1.4 mV) of QER-TFS confirmed their high stability. Compared with the QER solution, the optimized QER-TFS in situ gel formulation exhibited sustained release behavior and augmented nasal mucosa permeability. CT scanning of rat brains demonstrated the buildup of gold nanoparticles (GNPs) in the brains of all treatment groups, with a greater level of GNPs noted in the rats given the transferosomal gel. Additionally, in vitro studies on PCS-200-014 cells revealed minimal cytotoxicity of QER-TFS in situ gel. Based on these results, the developed transferosomal nanovesicles may be a suitable nanocarrier for QER brain targeting through the intranasal route.

Schlagwörter

Stichwörter der Autor:innen

CT scanbrain targetingcytotoxicityintranasalquercetintransferosomes

Autor:innen und Institutionen

  • Department of Pharmaceutics, College of Pharmacy, Jouf University, Sakaka 72341, Saudi Arabia.
  • Department of Pharmaceutics, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia.
  • Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Beni-Suef University, Beni-Suef 62511, Egypt.
  • Department of Pharmaceutical Chemistry, College of Pharmacy, Jouf University, Sakaka 72341, Saudi Arabia.
  • Department of Pharmacology, Faculty of Veterinary Medicine, Beni-Suef University, Beni-Suef 62511, Egypt.
  • School of Computing, Engineering & Physical Sciences, University of the West of Scotland, Paisley PA1 2BE, UK.

ORCID-Profile: Mohammed H Elkomy, Omar A Alsaidan, Mohammed Elmowafy, Ameeduzzafar Zafar, Mohamed A Abdelgawad, Fatma I Abo El-Ela, Mostafa E Rateb, Ibrahim A Naguib, Hussein M Eid

Förderung

  • CSR NIH HHS
  • Deanship of Scientific Research at Jouf University

Zitieren

APA

Elkomy, M. H., Zaki, R. M., Alsaidan, O. A., Elmowafy, M., Zafar, A., Shalaby, K., Abdelgawad, M. A., Abo El-Ela, F. I., Rateb, M. E., Naguib, I. A., & Eid, H. M. (2023). Intranasal Nanotransferosomal Gel for Quercetin Brain Targeting: I. Optimization, Characterization, Brain Localization, and Cytotoxic Studies. Pharmaceutics, 15(7), 1805. https://doi.org/10.3390/pharmaceutics15071805

Vancouver

Elkomy MH, Zaki RM, Alsaidan OA, Elmowafy M, Zafar A, Shalaby K, et al. Intranasal Nanotransferosomal Gel for Quercetin Brain Targeting: I. Optimization, Characterization, Brain Localization, and Cytotoxic Studies. Pharmaceutics. 2023;15(7):1805. doi:10.3390/pharmaceutics15071805

BibTeX
@article{Elkomy2023,
  author = {Elkomy, Mohammed H and Zaki, Randa Mohammed and Alsaidan, Omar A and Elmowafy, Mohammed and Zafar, Ameeduzzafar and Shalaby, Khaled and Abdelgawad, Mohamed A and Abo El-Ela, Fatma I and Rateb, Mostafa E and Naguib, Ibrahim A and Eid, Hussein M},
  title = {Intranasal Nanotransferosomal Gel for Quercetin Brain Targeting: I. Optimization, Characterization, Brain Localization, and Cytotoxic Studies},
  journal = {Pharmaceutics},
  year = {2023},
  volume = {15},
  number = {7},
  pages = {1805},
  doi = {10.3390/pharmaceutics15071805}
}
Kostenlos starten →